What are the common side effects of tofacitinib citrate tablets?

Tofacitinib (Tofacitinib), as a JAK inhibitor, is widely used to treat autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and ulcerative colitis. However, despite its remarkable efficacy, there are still some common side effects that patients and doctors should be aware of.

The most frequent adverse reactions in patients treated for rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis include upper respiratory tract infection, nasopharyngitis, diarrhea, and headache. Upper respiratory tract infections often present with cough, sore throat and flu symptoms, conditions associated with reduced resistance after a suppressed immune system. Nasopharyngitis may cause patients to experience nasal congestion, runny nose and throat discomfort, which are also common symptoms after using tofacitinib.

For patients with ulcerative colitis, common side effects are more diverse and include nasopharyngitis, elevated cholesterol levels, headache, upper respiratory tract infection, elevated blood creatine phosphokinase, rash, diarrhea, and herpes zoster. Elevated cholesterol levels may be detected during treatment, and doctors usually monitor patients' blood lipids regularly so that timely measures can be taken to adjust the treatment plan. Diarrhea is also a side effect to be aware of, and patients may experience mild to moderate diarrhea symptoms that affect quality of life.

Similar side effects occur in patients with polyarticular juvenile idiopathic arthritis, with upper respiratory tract infection, nasopharyngitis, diarrhea, and headache being the most common adverse reactions. The occurrence of these side effects is often related to the effect of drugs on the immune system. Due to the suppression of immune function, patients are more susceptible to infections and other symptoms.

Overall, although tofacitinib citrate tablets perform well in controlling disease activity, the occurrence of side effects cannot be ignored. When using this drug, patients should maintain communication with their attending physician and regularly monitor their physical condition to detect and deal with potential adverse reactions in a timely manner.

Reference materials:https://www.xeljanz.com/